Rankings
▼
Calendar
SGHT Q4 2025 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SGHT
Sight Sciences, Inc.
$224M
Q4 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$20M
+6.9% YoY
Gross Profit
$18M
87.3% margin
Operating Income
-$4M
-18.0% margin
Net Income
-$4M
-20.4% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+2.4%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$115M
Total Liabilities
$51M
Stockholders' Equity
$64M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20M
$19M
+6.9%
Gross Profit
$18M
$17M
+7.4%
Operating Income
-$4M
-$12M
+69.2%
Net Income
-$4M
-$12M
+64.9%
Revenue Segments
Surgical Glaucoma
$20M
96%
Dry Eye
$724,000
4%
← FY 2025
All Quarters